Thyroxine in human serum migrates during paper electrophoresis at pH 8.6 with at least three protein components: an a globulin intermediate between a1 and a2, thyroxine-binding protein (TBP) (1, 2), albumin (1, 2) and a component moving faster than albumin, prealbumin or thyroxinebinding prealbumin (TBPA) (3). Alterations in serum protein-bound iodine (PBI) may occur in certain circumstances without concomitant hyperor hypothyroidism, but with parallel changes in the thyroxine-binding capacity of TBP. Examples are the elevated PBI and TBP capacity in pregnancy (4, 5) and after estrogen therapy (6), and the depressed PBI and TBP capacity produced by methyl testosterone (7). It seemed logical, therefore, to look for alterations in TBP in patients with abnormal serum PBI levels in whom other evidence of thyroid dysfunction was lacking. We wish to report the occurrence of an elevated PBI and TBP capacity in an otherwise normal adult male and in one of his three children.
W.W. was a male 48 years of age when seen on March 17, 1958 , because his serum PBI was found to be "elevated" on a routine periodic health examination. He was asymptomatic and gave no history of thyroid disease in himself or in his family. He had never received radiographic contrast media and there was no known ingestion of other organic iodine compounds. He gave no history of diseases known to alter the serum proteins. His libido and potentia were considered to be normal. His physical examination was completely normal. No goiter or evidence of hyper-or hypothyroidism was evident. Hair growth and distribution and genitalia were normal.
His two sons, aged 18 and 12 years, and his daughter, aged 15 years, also presented no abnormal findings by medical history or physical examination except for the * Expense of this project was defrayed in part by grants from the United States Public Health Service (M-2399) and the Atomic Energy Commission Project No. 15. history of allergic asthma treated with potassium iodide in the 12 year old boy. The girl gave a normal menstrual history with onset at 12.5 years of age.
Pertinent laboratory findings on the father are presented in Table I . Normal values and references to the published techniques used in obtaining these laboratory data are also presented in this table.
Measurement of the thyroxine-binding capacity of TBP was done as before (8, 9) except that electrophoresis was carried out in 0.1 M ammonium carbonate as well as in barbital buffer. The pH of the solution of U.S.P. grade ammonium carbonate was adjusted to about pH 8.4 by bubbling CO2 through it for a few minutes. The pH on the paper strip at the end of the run was approximately 8.5 as determined by indicator paper. The thyroxine-binding capacity of TBP determined in ammonium carbonate is the same as when barbital is used (9) . Electrophoresis in the former, however, results in a large additional thyroxine peak running ahead of albumin similar to that found with "Tris" maleate buffer (3). In this study, two levels of added I'~-labeled L-thyroxine were employed: 2.69 fig. per ml. and 1.34 Mg. per ml. The former was done in triplicate and the latter in duplicate.
RESULTS
The findings in the father are given in Table I . The serum PBI and serum butanol extractable iodine (BEI) were elevated to two to three times the mean value found in normal individuals. The 1131-labeled triiodothyronine erythrocyte uptake (1131 T3 RBC uptake) which is reported to increase in hyperthyroidism (12, 22) was less than half of the lower limit of published normal values. The basal metabolic rate (BMR) and basal pulse rate were at the low normal to hypothyroid range. The serum cholesterol and I131 thyroid uptake were well within the normal range.
The disappearance of intravenously injected 1131 L-thyroxine from the plasma (expressed in Table   I as half time, T1/2, and as fraction of the thyroxine pool turned over per day) was slower than the normal mean by almost a factor of two and slower than reported in myxedema (14) . The extrathyroidal organic iodine pool (EOI) was 1683 
6.5-8. about twice as large as the normal mean and com-bromsulfalein retention, and urinary 17-ketoparable to that in thyrotoxicosis (14) . The degra-steroid excretion. The slightly elevated values for dation rate of thyroxine in micrograms per day 24 hour urinary estrogen excretion were of queswas, however, within the normal range. tionable significance, as was the low value for Normal values were found for serum proteins, urinary follicle stimulating hormone. The values for the normals were in the range previously reported for normal adults (8) . The results in Child 1 and Child 2 were also normal, but TBP in sera from the father and Child 3 had greater than normal capacity to bind thyroxine. The highest value was found in the father. Thyroxine-binding capacities determined with barbital buffer gave similar results. Representative electrophoretic patterns are presented in Figure 1 and demonstrated no abnormality other than the quantitative difference already noted. If, as seems likely, the increase in TBP capacity was the primary alteration, it is of interest to speculate on how the other observed abnormalities in thyroid physiology might have come about.
If it is assumed that thyroxine (or triiodothyronine) combined with serum protein is unavailable to the tissues and that the metabolic action of the hormones is exerted only by the diffusible free thyroxine, which is in equilibrium with the bound, then a higher total thyroxine level in serum would be required for maintenance of euthyroidism (2) . A normal thyroid-pituitary system would result, therefore, in an elevated serum PBI together with an expanded extrathyroidal thyroxine pool, as observed in the case presented. In the euthyroid steady state, however, the quantity of thyroxine degraded per day would be normal, so that the fraction of the total thyroxine pool turning over per day would be decreased. In this steady state the function of the thyroid gland would be no different from normal. The findings presented are compatible with such an hypothesis.
The depression in J131 T3 RBC uptake may also be explained by the increase in TBP capacity for thyroxine since triiodothvronine and thyroxine interact with the same sites on this protein (23) .
From the expression for an equilibrium reaction, (thyroxine bound to TBP) k (free thyroxine) = (unoccupied TBP sites)
If free thyroxine remains constant in the presence of an increase in total TBP sites and total serum thyroxine, then the concentration of unoccupied TBP sites must increase. The addition of a small increment in labeled thyroxine (or triiodothyronine) to such an altered serum would result in a greater normal proportion of the labeled substance being bound to TBP. There would then be less free labeled hormone available for uptake by the red blood cells even though the total quantity of hormone taken up might be normal. In the absence of other alterations affecting RBC uptake, the changes in TBP and PBI in the patient would, therefore, explain the lowered 1131 T3 RBC uptake.
The findings suggest that some of the instances of elevated serum PBI levels without accompany-ing hyperthyroidism, which are found sporadically and are usually attributed to contamination with nonhormonal iodine (24) , may be the result of an increase in the thyroxine-binding capacity of serum TBP. Tanaka and Starr (25) described 10 such patients, all of whom were women. The present report is, to our knowledge. the first indication that such an abnormality may be familial. The frequency of this abnormality is unknown. It is not unlikely that the more frequent application of the test of IP" T3 RBC uptake. even though subject to alteration by factors unrelated to TBP, mav serve to bring such cases to attention. M\Ieas-urement of TBP capacity in suspected cases would, of course, lbe a more direct approach.
It is also possible that alterations in TBP capacity can explain other paradoxical deviations in the PBI level. Tanaka 
